In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bird Rock Bio Inc.

www.birdrockbio.com

Latest From Bird Rock Bio Inc.

Impressive Clinical Results For Argenx’s Oncology Candidate Seal The Deal for Janssen

Janssen boosts its oncology pipeline with argenx’s novel anti-CD70 antibody, which has potential in a variety of indications.

Cancer Deals

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical

arGEN-X Plans IPO To Progress Pipeline And Attract Fresh Partnerships

Dutch antibody therapeutics developer arGEN-X BV will use proceeds from a planned summer IPO to progress three clinical assets and further develop its strategy targeting orphan indications, while adding to its growing list of big pharma partners in major indications.

BioPharmaceutical Netherlands

Execs On The Move, May 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • RuiYi Inc.
  • Borean Pharma AS
  • Anaphore Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bird Rock Bio Inc.
  • Senior Management
  • Paul A Grayson, Pres. & CEO
  • Contact Info
  • Bird Rock Bio Inc.
    Phone: (858) 587-4815
    2223 Avenida de la Playa
    Ste. 205
    La Jolla, CA 92037
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register